37. CLINICAL FEATURES, SUBCLINICAL CHARACTERISTICS AND RESULTS OF TARGET TREATMENT OF NON-SMALL CELL LUNG CANCER PATIENTS WITH DOUBLE MUTATIONS OF THE EGFR GENE PERIOD 2019-2023. YHCĐ. 2024;65(CĐ 3 - Bệnh viện Phổi Trung ương). doi:10.52163/yhc.v65iCD3.1134